CVS Caremark (CVS) Announces New $2B Buyback Program; Denton to Become CFO
More News related to CVS
- MinuteClinic Opens First Retail Clinic in Washington, D.C. at CVS/pharmacy Store in Northeast
- Brower Piven Encourages Investors Who Have Losses in Excess of $300,000 From Investment in CVS Caremark Corporation to Inquire About the Lead Plaintiff Position in Securities Fraud Class Action Lawsui
- CVS/pharmacy Kicks Off Annual Thanks and Giving(R) Campaign for the St. Jude Children's Research Hospital
- Stull, Stull & Brody Announces Class Action on Behalf of Shareholders of CVS Caremark Corporation
- Shalov Stone Bonner & Rocco LLP Announces Class Action Against CVS Caremark Corporation
More News related to Stock Buybacks
- WSP Holdings (WH) Approves $10M Stock Buyback
- Illumina (ILMN) Approves New $100M Buyback
- Tutor Perini (TPC) Extends $100 Million Stock Buyback Plan
- Pegasystems (PEGA) Approves Additional $15M Common Buyback
- Merck (MRK) Declares $0.38 Quarterly Dividend; 4.1% Yield; Announces $3B Common Buyback
CVS Caremark (NYSE: CVS) announces a new $2 billion buyback program.
The company also announced that David Denton will become the new CFO, replacing David Rickard who is retiring at the end of this year.
Related Categories
Management ChangesStock Buybacks
Stocks Mentioned
+0.00Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
